{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:23:15Z","timestamp":1791897795836,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/labinvest.2016.52","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T08:42:06Z","timestamp":1461573726000},"page":"773-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-\u03b2"],"prefix":"10.1016","volume":"96","author":[{"given":"Shaukat A","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mon-Li","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2016.52_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/CS20060342","article-title":"Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology","volume":"112","author":"Higuchi","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1038\/labinvest.2016.52_bib2","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1161\/01.CIR.96.11.4065","article-title":"Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation","volume":"96","author":"Weber","year":"1997","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2016.52_bib3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1146\/annurev.ph.57.030195.004105","article-title":"Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction","volume":"57","author":"Pfeffer","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"10.1038\/labinvest.2016.52_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","article-title":"Molecular mechanisms of myocardial remodeling","volume":"79","author":"Swynghedauw","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1038\/labinvest.2016.52_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1161\/01.CIR.100.20.2093","article-title":"Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction","volume":"100","author":"Harada","year":"1999","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2016.52_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0008-6363(99)00429-0","article-title":"Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodelling in rats","volume":"46","author":"Jain","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1038\/labinvest.2016.52_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2016.52_bib8","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/01.CIR.89.5.2273","article-title":"Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat","volume":"89","author":"Schieffer","year":"1994","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2016.52_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11926-002-0010-4","article-title":"Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis","volume":"4","author":"Verrecchia","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1038\/labinvest.2016.52_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J"},{"key":"10.1038\/labinvest.2016.52_bib11","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s00018-006-6085-8","article-title":"Role of transforming growth factor-beta in the progression of heart failure","volume":"63","author":"Lim","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1038\/labinvest.2016.52_bib12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-beta signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/labinvest.2016.52_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.RES.0000185833.42544.06","article-title":"Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure","volume":"97","author":"Wang","year":"2005","journal-title":"Circ Res"},{"key":"10.1038\/labinvest.2016.52_bib14","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1161\/01.CIR.0000165066.71481.8E","article-title":"Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure","volume":"111","author":"Okada","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2016.52_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","article-title":"Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats","volume":"106","author":"Kuwahara","year":"2002","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2016.52_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","article-title":"Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts","volume":"40","author":"Gray","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1038\/labinvest.2016.52_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-beta1 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1038\/labinvest.2016.52_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.carpath.2007.02.007","article-title":"Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis","volume":"16","author":"Chen","year":"2007","journal-title":"Cardiovasc Pathol"},{"key":"10.1038\/labinvest.2016.52_bib19","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1210\/en.2008-0165","article-title":"Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction","volume":"149","author":"Ellmers","year":"2008","journal-title":"Endocrinology"},{"key":"10.1038\/labinvest.2016.52_bib20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cardiores.2004.07.017","article-title":"Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction","volume":"64","author":"Ikeuchi","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1038\/labinvest.2016.52_bib21","doi-asserted-by":"crossref","first-page":"H1415","DOI":"10.1152\/ajpheart.01048.2009","article-title":"Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction","volume":"298","author":"Tan","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/labinvest.2016.52_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00395-008-0739-7","article-title":"Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction","volume":"103","author":"Frantz","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1038\/labinvest.2016.52_bib23","doi-asserted-by":"crossref","first-page":"H424","DOI":"10.1152\/ajpheart.00529.2009","article-title":"Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart","volume":"298","author":"Lucas","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/labinvest.2016.52_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cardiores.2004.06.006","article-title":"Matricellular proteins in the heart: possible role during stress and remodeling","volume":"64","author":"Schellings","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1038\/labinvest.2016.52_bib25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1152\/physrev.00008.2011","article-title":"Matricellular proteins in cardiac adaptation and disease","volume":"92","author":"Frangogiannis","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1038\/labinvest.2016.52_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.yjmcc.2011.11.001","article-title":"Loss of fibulin-2 protects against progressive ventricular dysfunction after myocardial infarction","volume":"52","author":"Tsuda","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/labinvest.2016.52_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/CS20120636","article-title":"Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-beta signalling","volume":"126","author":"Zhang","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"10.1038\/labinvest.2016.52_bib28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/MCB.01876-07","article-title":"Fibulin-2 is dispensable for mouse development and elastic fiber formation","volume":"28","author":"Sicot","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1038\/labinvest.2016.52_bib29","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.HYP.0000128621.68160.dd","article-title":"Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy","volume":"43","author":"Matsui","year":"2004","journal-title":"Hypertension"},{"key":"10.1038\/labinvest.2016.52_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/dvdy.1172","article-title":"Fibulin-2 expression marks transformed mesenchymal cells in developing cardiac valves, aortic arch vessels, and coronary vessels","volume":"222","author":"Tsuda","year":"2001","journal-title":"Dev Dyn"},{"key":"10.1038\/labinvest.2016.52_bib31","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1083\/jcb.123.5.1269","article-title":"Structures and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and concensus motif for calcium binding","volume":"123","author":"Pan","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1038\/labinvest.2016.52_bib32","doi-asserted-by":"crossref","first-page":"e26628","DOI":"10.1371\/journal.pone.0026628","article-title":"Transforming growth factor beta(1) oppositely regulates the hypertrophic and contractile response to beta-adrenergic stimulation in the heart","volume":"6","author":"Huntgeburth","year":"2011","journal-title":"PloS One"},{"key":"10.1038\/labinvest.2016.52_bib33","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1172\/JCI44824","article-title":"Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload","volume":"121","author":"Koitabashi","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2016.52_bib34","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/HYPERTENSIONAHA.109.147611","article-title":"Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling","volume":"55","author":"Huang","year":"2010","journal-title":"Hypertension"},{"key":"10.1038\/labinvest.2016.52_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pharmthera.2008.05.010","article-title":"Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks","volume":"119","author":"Schluter","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1038\/labinvest.2016.52_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejheart.2008.02.011","article-title":"Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure","volume":"10","author":"Koitabashi","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1038\/labinvest.2016.52_bib37","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI18389","article-title":"A friend within the heart: natriuretic peptide receptor signaling","volume":"111","author":"Molkentin","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2016.52_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mce.2007.05.003","article-title":"Cardiac BNP gene activation by angiotensin II in vivo","volume":"273","author":"Majalahti","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1038\/labinvest.2016.52_bib39","doi-asserted-by":"crossref","first-page":"e000078","DOI":"10.1161\/JAHA.113.000078","article-title":"Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling","volume":"2","author":"Karakikes","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1038\/labinvest.2016.52_bib40","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1253\/circj.CJ-14-0511","article-title":"Enhanced bioactive myocardial transforming growth factor-beta in advanced human heart failure","volume":"78","author":"Khan","year":"2014","journal-title":"Circ J"},{"key":"10.1038\/labinvest.2016.52_bib41","doi-asserted-by":"crossref","first-page":"11805","DOI":"10.1074\/jbc.M611029200","article-title":"A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization","volume":"282","author":"Kobayashi","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.52_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/excr.1996.0014","article-title":"Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice","volume":"222","author":"Fassler","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1038\/labinvest.2016.52_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCRESAHA.107.157677","article-title":"Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts","volume":"102","author":"Li","year":"2008","journal-title":"Circ Res"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest201652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201652","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722015379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722015379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:41:37Z","timestamp":1758397297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722015379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0023683722015379"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2016.52","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-\u03b2","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2016.52","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}